Keros Therapeutics, Inc. (KROS): 8-K filed Nov 5, 2026

Form type

8-K

Filing date

Nov 5, 2026

Accession number

0001664710-26-000065

Filer

Keros Therapeutics, Inc. (CIK 1664710)